ACRO Creates CRO Forum to Liaise with TransCelerate BioPharma
ACRO announced its plans to establish a CRO Forum
The Association of Clinical Research Organizations (ACRO) announced its plans to establish a CRO Forum to provide a formal mechanism for the CRO industry to furnish input into the work of TransCelerate BioPharma. The CRO Forum is expected to commence in January 2015 and is open to all CROs. Participation is included as a benefit of ACRO membership. The CRO Forum will provide subject matter experts from its participants as liaisons to relevant TransCelerate workstreams.
Read the full release here.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
CAHtalyst Trial Shows Crenessity Sustains Efficacy in Classic Congenital Adrenal Hyperplasia
July 14th 2025Results from the Phase III CAHtalyst show that patients treated with Crenessity for classic congenital adrenal hyperplasia achieved and maintained lower, more physiologic glucocorticoid doses while keeping key adrenal biomarkers at or below baseline levels.
Baxdrostat Shows Significant Blood Pressure Reduction in Phase III BaxHTN Trial
July 14th 2025In the BaxHTN Phase III study, AstraZeneca’s baxdrostat demonstrated statistically significant and clinically meaningful reductions in systolic blood pressure in patients with uncontrolled or treatment-resistant hypertension.
